Purification and characterization of an enkephalin aminopeptidase from rat brain membranes

A membrane-bound aminopeptidase was purified from rat brain, and its activity was assayed by high-pressure liquid chromatography with Met-enkephalin as the substrate. The enzyme was extracted with 1% Triton X-100 and purified by chromatography, successively on DEAE-Sepharose CL-6B, Bio-Gel HTP, and Sephadex G-200 columns. The overall purification was about 1200-fold, with 25% yield. The purified enzyme showed one band on disc gel electrophoresis and two bands on sodium dodecyl sulfate electrophoresis with molecular weights of 62 000 and 66 000. The aminopeptidase has a pH optimum of 7.0, a Km of 0.28 mM, and a Vmax of 45 mumol (mg of protein)-1 min-1 for Met-enkephalin. It releases tyrosine from Met-enkephalin, but it does not split the byproduct. It does not hydrolyze gamma- or beta-endorphin, or dynorphin, but it does hydrolyze neutral and basic aminoacyl beta-naphthylamides. The enzyme is inhibited by the aminopeptidase inhibitors amastatin, bestatin, and bestatin-Gly. Its properties, such as its subcellular localization, substrate specificity, pH optimum, and molecular weight, distinguish it from leucine aminopeptidase, aminopeptidase A, aminopeptidase B, aminopeptidase M, and the soluble aminopeptidase for enkephalin degradation.

The effect of naloxone on enkephalin catabolism

Naloxone strongly inhibited the breakdown of Met- and Leu-enkephalin when the substrate was incubated with brain homogenate, supernatant, or partially purified soluble aminopeptidase, but it had no effect on the mitochondrial fraction. Arylamidase was also inhibited by naloxone. The inhibitory effect of naloxone on the soluble aminopeptidase was in a linear relationship with concentration in the range of 8-500 microM. The KI for Met-enkephalin is 0.6 mM and for Leu-enkephalin is 2.0 mM. When the naloxone was administered intraperitoneally to the mice, its effects were somewhat different from its effects in vitro. It inhibited the brain catabolism of Met-enkephalin but not of Leu-enkephalin or Tyr-beta NA in vitro. In vivo, acute morphine in mice decreased the Met-enkephalin hydrolysis but increased the Leu-enkephalin hydrolysis. Chronic morphine (by morphine pellet implantation) increased the breakdown rate of enkephalin and of Tyr-beta NA. Naloxone (1 mg/kg) could not reverse the effects of morphine, although abstinence syndrome and stereotypical jumping were precipitated. Naloxone decreased the Leu-enkephalin level in the control mice but did not affect it in the addicted mice.

Topography of the synaptosomal membrane

The composition and disposition of the constituent polypeptides of rat cerebral cortical synaptosomal membranes were analyzed on SDS acrylamide gels. Of 20 bands readily detected, 11 account for greater than 93% of the total protein analyzed. These are: (molecu25); 3 (175); 4 (doublet, 137); 5 (doublet, 97); 6 (68); 7 (61); 8 (54); 9 (44); 10 (37); and 11 (33). Bands 5 and 8-10 are the most prominent and account for greater than 60% of the protein mass or 0.67 of its molecular fraction. By lactoperoxidase iodination, the bulk of the proteins in bands 3, 5, 6, and 8 and a portion of band 11 appear to be located on the external (junctional) face of the membrane of intact synaptosomes; proteins in bands 1, 2, 7, 9, and 10 appear to be localized on the internal (synaptoplasmic) face and become labeled only when synaptosomes are lysed. Further confirmation of the topographical distribution is provided by evidence that bands 3-6, 8, and 11 contain glycoproteins susceptible to labeling in intact synaptosomes by oxidation with galactose oxidase or periodate followed by reduction with NaB3H4. Evidence is provided for significant contributions by tubulin- and actin-like molecules to bands 8 and 9, respectively, suggesting that a substantial fraction of the tubulin in the synaptosomal membrane is disposed externally (accessible to iodination) whereas most, if not all, of the actin appears to exhibit the opposite topography. Similar though weaker inferences can also be drawn with regard to the location of tropomyosin and troponin. Preliminary evidence is provided that postsynaptic densities exhibit a protein and iodination profile distinct from that of the synpatosomal membrane.